FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3160295311> ?p ?o ?g. }

• W3160295311 abstract "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), a rapidly evolving pandemic worldwide with at least 68 million COVID-19-positive cases and a mortality rate of about 2.2%, as of 10 December 2020. About 20% of COVID-19 patients exhibit moderate to severe symptoms. Severe COVID-19 manifests as acute respiratory distress syndrome (ARDS) with elevated plasma proinflammatory cytokines, including interleukin 1β (IL-1β), IL-6, tumor necrosis factor α (TNF-α), C-X-C motif chemokine ligand 10 (CXCL10/IP10), macrophage inflammatory protein 1 alpha (MIP-1α), and chemokine (C-C motif) ligand 2 (CCL2), with low levels of interferon type I (IFN-I) in the early stage and elevated levels of IFN-I during the advanced stage of COVID-19. Most of the severe and critically ill COVID-19 patients have had preexisting comorbidities, including hypertension, diabetes, cardiovascular diseases, and respiratory diseases. These conditions are known to perturb the levels of cytokines, chemokines, and angiotensin-converting enzyme 2 (ACE2), an essential receptor involved in SARS-CoV-2 entry into the host cells. ACE2 downregulation during SARS-CoV-2 infection activates the angiotensin II/angiotensin receptor (AT1R)-mediated hypercytokinemia and hyperinflammatory syndrome. However, several SARS-CoV-2 proteins, including open reading frame 3b (ORF3b), ORF6, ORF7, ORF8, and the nucleocapsid (N) protein, can inhibit IFN type I and II (IFN-I and -II) production. Thus, hyperinflammation, in combination with the lack of IFN responses against SARS-CoV-2 early on during infection, makes the patients succumb rapidly to COVID-19. Therefore, therapeutic approaches involving anti-cytokine/anti-cytokine-signaling and IFN therapy would favor the disease prognosis in COVID-19. This review describes critical host and viral factors underpinning the inflammatory cytokine storm induction and IFN antagonism during COVID-19 pathogenesis. Therapeutic approaches to reduce hyperinflammation and their limitations are also discussed." @default.
• W3160295311 created "2021-05-24" @default.
• W3160295311 creator A5000847606 @default.
• W3160295311 creator A5072211764 @default.
• W3160295311 date "2021-06-16" @default.
• W3160295311 modified "2023-10-16" @default.
• W3160295311 title "Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis" @default.
• W3160295311 cites W14453559 @default.
• W3160295311 cites W1547512866 @default.
• W3160295311 cites W1560860164 @default.
• W3160295311 cites W1579113972 @default.
• W3160295311 cites W1639795491 @default.
• W3160295311 cites W1786795173 @default.
• W3160295311 cites W1843578997 @default.
• W3160295311 cites W190626844 @default.
• W3160295311 cites W1906352940 @default.
• W3160295311 cites W1922412259 @default.
• W3160295311 cites W1965280032 @default.
• W3160295311 cites W1966135195 @default.
• W3160295311 cites W1967376766 @default.
• W3160295311 cites W1969841753 @default.
• W3160295311 cites W1972032770 @default.
• W3160295311 cites W1975501001 @default.
• W3160295311 cites W1976483167 @default.
• W3160295311 cites W1981987573 @default.
• W3160295311 cites W1994545268 @default.
• W3160295311 cites W1999592443 @default.
• W3160295311 cites W2000665020 @default.
• W3160295311 cites W2001411396 @default.
• W3160295311 cites W2022879707 @default.
• W3160295311 cites W2025638633 @default.
• W3160295311 cites W2031182394 @default.
• W3160295311 cites W2031432627 @default.
• W3160295311 cites W2032537032 @default.
• W3160295311 cites W2033023829 @default.
• W3160295311 cites W2036594413 @default.
• W3160295311 cites W2062817591 @default.
• W3160295311 cites W2063407488 @default.
• W3160295311 cites W2065139062 @default.
• W3160295311 cites W2075530183 @default.
• W3160295311 cites W2076362159 @default.
• W3160295311 cites W2096549714 @default.
• W3160295311 cites W2103091783 @default.
• W3160295311 cites W2125605037 @default.
• W3160295311 cites W2131213271 @default.
• W3160295311 cites W2132637517 @default.
• W3160295311 cites W2135264287 @default.
• W3160295311 cites W2138338247 @default.
• W3160295311 cites W2143314736 @default.
• W3160295311 cites W2144787399 @default.
• W3160295311 cites W2148802014 @default.
• W3160295311 cites W2154850912 @default.
• W3160295311 cites W2159705610 @default.
• W3160295311 cites W2163067702 @default.
• W3160295311 cites W2168822788 @default.
• W3160295311 cites W2267315119 @default.
• W3160295311 cites W2337855427 @default.
• W3160295311 cites W2347103927 @default.
• W3160295311 cites W2416569243 @default.
• W3160295311 cites W2585273079 @default.
• W3160295311 cites W2595833380 @default.
• W3160295311 cites W2612768906 @default.
• W3160295311 cites W2614287093 @default.
• W3160295311 cites W2735527928 @default.
• W3160295311 cites W2744892122 @default.
• W3160295311 cites W2766244100 @default.
• W3160295311 cites W2792274845 @default.
• W3160295311 cites W2803294153 @default.
• W3160295311 cites W2889848040 @default.
• W3160295311 cites W2899747393 @default.
• W3160295311 cites W2904662596 @default.
• W3160295311 cites W2952414199 @default.
• W3160295311 cites W2953152674 @default.
• W3160295311 cites W3001118548 @default.
• W3160295311 cites W3001897055 @default.
• W3160295311 cites W3002108456 @default.
• W3160295311 cites W3002539152 @default.
• W3160295311 cites W3003217347 @default.
• W3160295311 cites W3003347489 @default.
• W3160295311 cites W3003464757 @default.
• W3160295311 cites W3004280078 @default.
• W3160295311 cites W3004318991 @default.
• W3160295311 cites W3004668429 @default.
• W3160295311 cites W3006419170 @default.
• W3160295311 cites W3007336436 @default.
• W3160295311 cites W3008028633 @default.
• W3160295311 cites W3008295344 @default.
• W3160295311 cites W3008526620 @default.
• W3160295311 cites W3008827533 @default.
• W3160295311 cites W3008891488 @default.
• W3160295311 cites W3009409276 @default.
• W3160295311 cites W3009906937 @default.
• W3160295311 cites W3010123202 @default.
• W3160295311 cites W3010126769 @default.
• W3160295311 cites W3011176674 @default.
• W3160295311 cites W3011242477 @default.
• W3160295311 cites W3011483298 @default.
• W3160295311 cites W3011488280 @default.
• W3160295311 cites W3012421327 @default.
• W3160295311 cites W3012610905 @default.

• next